GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

China Resources Medical Holdings Company 1515.HK · HKD

Health Care · HKEX · 🇭🇰 Hong Kong

Compare

2.55

+0.39%

Close of 9 Nov 2026, in HKD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue

CN¥10.68bn

FY2016FY2025

Net income

CN¥577.5m

FY2016FY2025

Free cash flow

CN¥983.3m

FY2016FY2025

Shareholders' equity

CN¥7.63bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueCN¥10.68bnCN¥11.48bnCN¥11.77bnCN¥9.20bnCN¥5.18bnCN¥3.20bnCN¥2.46bnCN¥2.40bnCN¥2.19bnCN¥1.78bn
Gross profitCN¥1.68bnCN¥2.11bnCN¥2.22bnCN¥1.52bnCN¥1.09bnCN¥741.2mCN¥887.7mCN¥881.1mCN¥778.1mCN¥473.5m
Operating incomeCN¥492.0mCN¥876.5mCN¥992.6mCN¥514.2mCN¥428.1mCN¥323.8mCN¥592.4mCN¥620.9mCN¥531.7mCN¥273.1m
Net incomeCN¥577.5mCN¥658.9mCN¥300.1mCN¥309.6mCN¥486.6mCN¥361.1mCN¥455.1mCN¥501.8mCN¥490.3m−CN¥1.75bn
Diluted earnings per share0.460.520.240.240.380.290.360.400.38-1.79

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsCN¥15.04bnCN¥15.51bnCN¥15.90bnCN¥20.75bnCN¥12.19bnCN¥10.44bnCN¥9.17bnCN¥8.52bnCN¥8.05bnCN¥7.51bn
Cash and short-term investmentsCN¥1.20bnCN¥1.14bnCN¥1.44bnCN¥3.99bnCN¥3.07bnCN¥3.46bnCN¥2.65bnCN¥2.21bnCN¥1.85bnCN¥1.38bn
Total liabilitiesCN¥5.86bnCN¥6.78bnCN¥7.73bnCN¥8.34bnCN¥4.22bnCN¥3.05bnCN¥2.02bnCN¥1.87bnCN¥1.53bnCN¥1.27bn
DebtCN¥824.2mCN¥1.73bnCN¥2.69bnCN¥2.40bnCN¥1.73bnCN¥750.5mCN¥597.2mCN¥490.7mCN¥171.4m—
Shareholders' equityCN¥7.63bnCN¥7.24bnCN¥6.77bnCN¥11.07bnCN¥7.51bnCN¥7.11bnCN¥6.87bnCN¥6.51bnCN¥6.38bnCN¥6.10bn
Shares outstanding1,264m1,264m1,264m1,266m1,264m1,262m1,259m1,257m1,278m980m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsCN¥1.58bnCN¥1.48bnCN¥1.39bnCN¥729.6mCN¥827.3mCN¥749.6mCN¥426.3mCN¥389.1mCN¥535.1mCN¥260.6m
Capital spending−CN¥598.7m−CN¥656.4m−CN¥566.7m−CN¥294.5m−CN¥231.1m−CN¥244.0m−CN¥42.3m−CN¥67.1m−CN¥40.2m−CN¥49.4m
Free cash flowCN¥983.3mCN¥822.8mCN¥825.0mCN¥435.2mCN¥596.2mCN¥505.5mCN¥383.9mCN¥322.0mCN¥494.9mCN¥211.2m
Dividends paid−CN¥194.3m−CN¥162.0m−CN¥49.3m−CN¥150.9m−CN¥106.1m−CN¥134.0m−CN¥153.1m−CN¥138.1m−CN¥81.4m−CN¥96.8m

Latest quarters

By quarter end

Jun 2026Dec 2025Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Dec 2022
RevenueCN¥5.14bnCN¥5.42bnCN¥5.27bnCN¥5.68bnCN¥5.79bnCN¥5.81bnCN¥5.96bnCN¥5.47bn
Gross profitCN¥941.5mCN¥848.0mCN¥829.7mCN¥900.7mCN¥1.21bnCN¥950.6mCN¥1.27bnCN¥815.5m
Operating incomeCN¥417.4mCN¥224.7mCN¥267.3mCN¥230.5mCN¥655.2mCN¥257.1mCN¥735.6mCN¥196.3m
Net incomeCN¥304.2mCN¥182.1mCN¥395.4mCN¥153.6mCN¥505.3m−CN¥163.0mCN¥463.1mCN¥24.7m
Diluted earnings per share0.240.140.310.120.40-0.130.370.02
Cash from operations—CN¥1.06bnCN¥722.0mCN¥887.0mCN¥591.0mCN¥762.0mCN¥629.0mCN¥893.0m
Capital spending—−CN¥341.0m−CN¥271.0m−CN¥367.0m−CN¥289.0m−CN¥341.0m−CN¥225.0m−CN¥416.0m
Free cash flow—CN¥722.0mCN¥451.0mCN¥520.0mCN¥302.0mCN¥421.0mCN¥404.0mCN¥477.0m
Total assetsCN¥15.12bnCN¥15.04bnCN¥15.82bnCN¥15.51bnCN¥15.97bnCN¥15.90bnCN¥21.55bnCN¥12.93bn
Cash and short-term investmentsCN¥1.25bnCN¥1.20bnCN¥1.45bnCN¥1.14bnCN¥1.50bnCN¥1.44bnCN¥5.11bnCN¥3.84bn
DebtCN¥864.4mCN¥993.4mCN¥1.78bnCN¥1.86bnCN¥2.51bnCN¥2.69bnCN¥2.94bnCN¥2.80bn
Shareholders' equityCN¥7.81bnCN¥7.63bnCN¥7.51bnCN¥7.24bnCN¥7.18bnCN¥6.77bnCN¥6.94bnCN¥7.52bn

Financial ratios

Data as of 22 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin15.7%18.4%18.9%16.5%21.0%23.1%
Operating margin4.6%7.6%6.0%6.1%8.3%10.1%
Net margin5.4%5.7%2.5%3.4%9.4%11.3%
Return on equity7.6%9.1%4.4%2.8%6.5%5.1%
Return on assets3.8%4.2%1.9%1.5%4.0%3.5%
Free cash flow yield63.4%62.1%57.0%29.7%30.8%29.0%
Revenue growth-6.9%-2.5%27.9%77.7%61.7%30.0%
Earnings growth-12.4%119.6%-3.1%-36.4%34.8%-20.7%
Current ratio0.64x0.72x0.66x1.32x1.14x1.88x
Debt to equity0.11x0.24x0.38x0.25x0.26x0.12x
Equity ratio50.7%46.7%42.6%53.4%61.6%68.1%
Interest coverage8.75x12.34x5.29x8.57x22.65x16.34x
Buybacks as a share of market value0.0%0.0%0.2%-0.1%-0.2%-0.2%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue5.1%27.2%20.9%
Operating income-1.5%8.7%8.9%
Net income23.1%9.8%11.5%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin17.1%17.4%18.2%20.6%
Operating margin6.2%6.7%7.0%9.5%
Net margin5.6%4.3%5.2%4.2%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings6.16.717.620.410.420.210.811.122.2-4.8
Price to sales0.30.40.50.71.02.32.02.35.04.7

Dividends and splits

Per share, in the currency the company pays

Paid for 12 years. Last went ex-dividend on 30 Jun 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year0.0970.1440.1210.0370.120.0880.100.12

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.